Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.68 HKD | +1.10% | +0.55% | -50.90% |
05-30 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
05-28 | ImmuneOnco Biopharmaceuticals Inc. Approves the Appointment of Guan Mei as Executive Director | CI |
Evolution of the average Target Price on ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Chiffre d''affaires - Rate of surprise
- Stock Market
- Equities
- 1541 Stock
- Consensus ImmuneOnco Biopharmaceuticals (Shanghai) Inc.